Lexaria Bioscience Corp (LEXXW) — Capital Reinvestment Ratio
Latest as of November 2013:
0.37x
Lexaria Bioscience Corp (LEXXW) has a Capital Reinvestment Ratio of 0.37x as of November 2013, meaning it reinvests 0% of its operating cash flow ($74.27K) in capital expenditures ($27.23K). See Lexaria Bioscience Corp free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.37x
Capex / Operating Cash Flow
Operating Cash Flow
$74.27K
USD
Capital Expenditures
$27.23K
USD
Data as of
Nov 2013
Most recent filing
Lexaria Bioscience Corp Capital Reinvestment Ratio (2007–2014)
This chart tracks Lexaria Bioscience Corp's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Lexaria Bioscience Corp (2007–2014)
Year-by-year Capital Reinvestment Ratio for Lexaria Bioscience Corp from 2007 to 2014. For live market cap and broader valuation context, see Lexaria Bioscience Corp (LEXXW) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2014 | 0.29x | $321.00K | $91.61K | ▲ +0.0% |
| 2013 | 0.29x | $321.00K | $91.61K | ▲ +0.0% |
| 2012 | 0.29x | $321.00K | $91.61K | ▼ -85.8% |
| 2011 | 2.02x | $135.94K | $274.13K | ▼ -77.9% |
| 2010 | 9.13x | $109.84K | $1.00 Million | ▼ -54.5% |
| 2007 | 20.06x | $29.04K | $582.43K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow